Recheck A1c in 3 Months
For this patient with an A1c of 12% (up from 8.0 six months ago) who is restarting diabetes medications today, you should recheck the A1c in 3 months, not 1 month. 1
Rationale Based on Current Guidelines
The 2025 American Diabetes Association Standards of Care explicitly recommend assessing glycemic status every 3 months for individuals who are:
- Not meeting glycemic goals (your patient's A1c of 12% is far above target)
- Have recent treatment changes (restarting medications today qualifies)
- Have unstable glucose levels (demonstrated by the 4-point rise from 8.0% to 12%) 1
Why Not 1 Month?
A1c reflects average glycemia over approximately 2-3 months due to the lifespan of red blood cells 1. Testing at 1 month would be:
- Too early to capture meaningful change in glycemic control from the restarted medications
- Wasteful and not evidence-based
- Potentially misleading as the A1c would still predominantly reflect the period of non-compliance
Research confirms that quarterly (3-month) testing is optimal for achieving the best downward trajectory in A1c, particularly in patients with A1c ≥7%. Testing more frequently than every 3 months provides no additional benefit 2.
Additional Monitoring Considerations
While waiting 3 months for A1c reassessment:
- Consider continuous glucose monitoring (CGM) or self-monitoring of blood glucose to assess early response to therapy and medication adherence 1
- This allows you to detect problems with compliance or inadequate response before the 3-month mark
- Point-of-care A1c at the 3-month visit can provide immediate results for treatment adjustments 1
Common Pitfall to Avoid
Do not interpret an A1c checked at 1 month as a true reflection of treatment response—it will still largely reflect the pre-treatment period of non-compliance. This could lead to premature medication intensification when the current regimen hasn't had adequate time to demonstrate its effect.